Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VENUS REMEDIES SUN PHARMA VENUS REMEDIES/
SUN PHARMA
 
P/E (TTM) x 15.0 43.2 34.8% View Chart
P/BV x 0.9 6.9 13.6% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 VENUS REMEDIES   SUN PHARMA
EQUITY SHARE DATA
    VENUS REMEDIES
Mar-23
SUN PHARMA
Mar-23
VENUS REMEDIES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs3791,072 35.3%   
Low Rs145790 18.4%   
Sales per share (Unadj.) Rs415.5182.9 227.2%  
Earnings per share (Unadj.) Rs19.935.7 55.7%  
Cash flow per share (Unadj.) Rs44.046.2 95.3%  
Dividends per share (Unadj.) Rs011.50 0.0%  
Avg Dividend yield %01.2 0.0%  
Book value per share (Unadj.) Rs344.3233.4 147.5%  
Shares outstanding (eoy) m13.372,399.34 0.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.65.1 12.4%   
Avg P/E ratio x13.226.1 50.5%  
P/CF ratio (eoy) x5.920.1 29.5%  
Price / Book Value ratio x0.84.0 19.1%  
Dividend payout %032.2 0.0%   
Avg Mkt Cap Rs m3,5012,233,361 0.2%   
No. of employees `000NANA-   
Total wages/salary Rs m57082,960 0.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5,555438,857 1.3%  
Other income Rs m1038,199 1.3%   
Total revenues Rs m5,658447,055 1.3%   
Gross profit Rs m602112,900 0.5%  
Depreciation Rs m32325,294 1.3%   
Interest Rs m31,720 0.2%   
Profit before tax Rs m37994,084 0.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1148,476 1.3%   
Profit after tax Rs m26685,608 0.3%  
Gross profit margin %10.825.7 42.1%  
Effective tax rate %30.09.0 332.6%   
Net profit margin %4.819.5 24.5%  
BALANCE SHEET DATA
Current assets Rs m3,230398,619 0.8%   
Current liabilities Rs m826199,064 0.4%   
Net working cap to sales %43.345.5 95.2%  
Current ratio x3.92.0 195.3%  
Inventory Days Days37147 25.1%  
Debtors Days Days50495 529.5%  
Net fixed assets Rs m2,781376,960 0.7%   
Share capital Rs m1342,399 5.6%   
"Free" reserves Rs m4,470557,555 0.8%   
Net worth Rs m4,603559,954 0.8%   
Long term debt Rs m3870-   
Total assets Rs m6,011775,794 0.8%  
Interest coverage x130.055.7 233.4%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.90.6 163.4%   
Return on assets %4.511.3 39.7%  
Return on equity %5.815.3 37.7%  
Return on capital %7.717.1 44.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m0154,053 0.0%   
Fx outflow Rs m071,511 0.0%   
Net fx Rs m082,541 0.0%   
CASH FLOW
From Operations Rs m36649,593 0.7%  
From Investments Rs m-508-79,437 0.6%  
From Financial Activity Rs m-623,761 -0.0%  
Net Cashflow Rs m-2201,155 -19.1%  

Share Holding

Indian Promoters % 41.8 54.5 76.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 36.6 4.3%  
FIIs % 1.6 17.1 9.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.2 45.5 127.9%  
Shareholders   19,560 612,626 3.2%  
Pledged promoter(s) holding % 0.0 2.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VENUS REMEDIES With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on VENUS REMEDIES vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VENUS REMEDIES vs Sun Pharma Share Price Performance

Period VENUS REMEDIES Sun Pharma S&P BSE HEALTHCARE
1-Day 7.05% 0.77% 1.18%
1-Month -4.10% 3.00% -0.75%
1-Year 103.11% 64.65% 61.82%
3-Year CAGR 4.62% 39.45% 18.16%
5-Year CAGR 58.05% 27.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the VENUS REMEDIES share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of VENUS REMEDIES hold a 41.8% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VENUS REMEDIES and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, VENUS REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.

You may visit here to review the dividend history of VENUS REMEDIES, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.